It’s always a good idea to pay attention to insider buying. After all, it’s the insiders who know their company the best. And ...

Illumina Inc. ILMN recently introduced PromoterAI, a new AI algorithm that accurately deciphers pathogenic regulatory genetic variants in the noncoding regions of the human genome. PromoterAI ...

Illumina, Inc. ILMN has received approval from Japan’s Ministry of Health, Labour and Welfare for TruSightTM Oncology (TSO) Comprehensive for Class III/IV Medical Device (Specially Controlled ...

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside ...

Investors in Illumina Inc (Symbol: ILMN) saw new options become available today, for the July 25th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ILMN ...

Illumina Inc. (NASDAQ: ILMN), aligned with its commitments to advance the power of genomics, today published its annual ...

Genomics company Illumina (NASDAQ:ILMN) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales fell ...

Incyte Corporation (NASDAQ:INCY) is one of the 10 biotech stocks screaming a buy. On June 17, Incyte was a big mover in the ...

On Tuesday, Canaccord Genuity analysts increased the price target for Illumina stock (NASDAQ: NASDAQ: ILMN) to $99 from $87 while maintaining a Hold rating.The stock, which has declined nearly 25% ...

Illumina Inc. (NASDAQ: ILMN), aligned with its commitments to advance the power of genomics, today published its annual Corporate Social Responsibility (CSR) Report. The report spotlights the ways ...

Illumina, Inc. (NASDAQ:ILMN) has introduced PromoterAI, a breakthrough AI tool designed to detect disease-causing mutations in the noncoding promoter regions of the genome, areas often overlooked ...